Literature DB >> 3533982

Detection of Campylobacter pyloridis in patients with antrum gastritis and peptic ulcers by culture, complement fixation test, and immunoblot.

H von Wulffen, J Heesemann, G H Bützow, T Löning, R Laufs.   

Abstract

The association of Campylobacter pyloridis with antrum gastritis and peptic ulcers was described. We investigated antral biopsies from 180 patients who underwent gastroscopy. By culture or Gram stain or both, we found overall 98 (54%) of them to be positive for C. pyloridis. In the various groups the following percentages were found to be positive: normal antral mucosa 3% (n = 30); moderate superficial antrum gastritis, 49% (n = 83); severe superficial antrum gastritis, 86% (n = 44); duodenal ulcer, 83% (n = 54); and gastric ulcer, 72% (n = 18). A serological screening that used a complement fixation test yielded the following results: highest rates of positive complement fixation titers were seen in patients with severe gastritis and those with duodenal ulcers, both with 79%; the lowest incidence was in a group of 20 blood donors, with 5%. Positive complement fixation titers in gastritis patients also correlated well with characteristic patterns on immunoglobulin G and A immunoblots, while there was no specific reactivity observed on immunoglobulin M immunoblots.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3533982      PMCID: PMC269015          DOI: 10.1128/jcm.24.5.716-720.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Pyloric campylobacter serology.

Authors:  B J Marshall; D B McGechie; G J Francis; P J Utley
Journal:  Lancet       Date:  1984-08-04       Impact factor: 79.321

2.  Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.

Authors:  B J Marshall; J R Warren
Journal:  Lancet       Date:  1984-06-16       Impact factor: 79.321

3.  Campylobacter-like organisms in the stomach of patients and healthy individuals.

Authors: 
Journal:  Lancet       Date:  1984-06-16       Impact factor: 79.321

4.  Polyacrylamide gel electrophoresis of spiral bacteria from the gastric antrum.

Authors:  A D Pearson; A Ireland; J Bamforth; C Walker; L Booth; P Hawtin; G Holdstock; H Millward-Sadler
Journal:  Lancet       Date:  1984-06-16       Impact factor: 79.321

5.  Gastric spiral bacteria.

Authors: 
Journal:  Lancet       Date:  1984-07-14       Impact factor: 79.321

6.  Unidentified curved bacilli on gastric epithelium in active chronic gastritis.

Authors:  J R Warren; B Marshall
Journal:  Lancet       Date:  1983-06-04       Impact factor: 79.321

7.  Immune response to Campylobacter pyloridis in patients with peptic ulceration.

Authors:  J Kaldor; W Tee; P McCarthy; J Watson; B Dwyer
Journal:  Lancet       Date:  1985-04-20       Impact factor: 79.321

8.  Campylobacter like organisms on the gastric mucosa: culture, histological, and serological studies.

Authors:  D M Jones; A M Lessells; J Eldridge
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

9.  A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots.

Authors:  M S Blake; K H Johnston; G J Russell-Jones; E C Gotschlich
Journal:  Anal Biochem       Date:  1984-01       Impact factor: 3.365

10.  Genetically manipulated virulence of Yersinia enterocolitica.

Authors:  J Heesemann; B Algermissen; R Laufs
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

View more
  40 in total

Review 1.  An assessment of serological tests for detection of Helicobacter pylori.

Authors:  H von Wulffen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-07       Impact factor: 3.267

2.  Serodiagnosis of Helicobacter pylori infections by detection of immunoglobulin G antibodies using an immunoblot technique and enzyme immunoassay.

Authors:  M Faulde; J P Schröder; D Sobe
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-07       Impact factor: 3.267

3.  Evaluation of a commercially available complement fixation test for diagnosis of Helicobacter pylori infection and for follow-up after antimicrobial therapy.

Authors:  H Goossens; Y Glupczynski; A Burette; C Van den Borre; C DePrez; J Bodenmann; A Keller; J P Butzler
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

4.  Elevated risk of Helicobacter pylori infection in submarine crews.

Authors:  I Hammermeister; G Janus; F Schamarowski; M Rudolf; E Jacobs; M Kist
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-01       Impact factor: 3.267

5.  Association between Helicobacter pylori infection and serum pepsinogen concentrations in gastroduodenal disease.

Authors:  K Matsumoto; N Konishi; M Ohshima; Y Hiasa; E Kimura; T Samori
Journal:  J Clin Pathol       Date:  1996-12       Impact factor: 3.411

6.  Serum antibody responses to the N-acetylneuraminyllactose-binding hemagglutinin of Campylobacter pylori.

Authors:  D J Evans; D G Evans; K E Smith; D Y Graham
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

Review 7.  Diagnosis of Helicobacter pylori.

Authors:  U Blecker; D I Mehta
Journal:  Indian J Pediatr       Date:  1997 Nov-Dec       Impact factor: 1.967

8.  Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism.

Authors:  U E Mai; G I Perez-Perez; L M Wahl; S M Wahl; M J Blaser; P D Smith
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

9.  Value of whole-cell antigen extracts for serologic detection of Helicobacter pylori.

Authors:  S M Salama; J N Wefuan; S Shiro-Koulla; A Mbakop; M Tagni-Sartre; E C Ndam; J L Ngu; D E Taylor
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

10.  A better method for confirming Helicobacter pylori infection in Mongolian gerbils.

Authors:  Chao-Hung Kuo; Huang-Ming Hu; Pei-Yun Tsai; Sheau-Fang Yang; Lin-Li Chang; Jaw-Yuan Wang; Angela Chen; Chang-Ming Jan; Wen-Ming Wang; Deng-Chyang Wu
Journal:  J Gastroenterol       Date:  2008-02-24       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.